SINOPHARM : Announcements and Notices - Supplemental Notice of AGM

f55a06c3-97ca-4dd6-9277-043d224e1477.pdf

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

SINOPHARM GROUP CO. LTD.*

國 藥 控 股 股 份 有 限 公 司

(A joint stock limited company incorporated in the People's Republic of China with limited liability and carrying on business in Hong Kong as 國控股份有限公司)

(Stock Code: 01099) SUPPLEMENTAL NOTICE OF AGM

Reference is made to the notice of the 2015 annual general meeting (the "AGM") of Sinopharm Group Co. Ltd. (the "Company") dated 29 April 2016 (the "Notice") which sets out the time and venue of the AGM and contains the resolutions to be proposed at the AGM for shareholders' approval.

SUPPLEMENTAL NOTICE IS HEREBY GIVEN that the AGM will be held as originally scheduled at Meeting Room 1813, Sinopharm Plaza, No. 1001 Zhongshan West Road, Changning District, Shanghai, the People's Republic of China (the "PRC") at 9:00 a.m. on Thursday, 16 June 2016 for the purpose of considering, and if thought fit, passing the following resolutions in addition to the resolutions set out in the Notice: ORDINARY RESOLUTIONS

1. To consider and approve the appointment of Ernst & Young Hua Ming LLP as the domestic auditor of the Company (to replace PricewaterhouseCoopers Zhong Tian LLP) to hold office until conclusion of the next annual general meeting, and to ratify and confirm its remuneration determined by the audit committee of the board of the Company.

   * The Company is registered as a non-Hong Kong company under the Hong Kong Companies Ordinance under its Chinese name and the English name "Sinopharm Group Co. Ltd."

2. To consider and approve the appointment of Ernst &Young as the international auditor of the Company (to replace PricewaterhouseCoopers) to hold office until conclusion of the next annual general meeting, and to ratify and confirm its remuneration determined by the audit committee of the board of the Company.

By Order of the Board of

Sinopharm Group Co. Ltd. Wei Yulin

Chairman

Shanghai, the PRC 31 May 2016

As at the date of this notice, the executive directors of the Company are Mr. Wei Yulin and Mr. Li Zhiming; the non-executive directors of the Company are Mr. Chen Qi Yu, Mr. She Lulin, Mr. Wang Qunbin, Mr. Li Yuhua, Mr. Deng Jindong, Mr. Li Dongjiu, Mr. Liu Hailiang and Mr. Lian Wanyong; and the independent non-executive directors of the Company are Ms. Li Ling, Mr. Yu Tze Shan Hailson, Mr. Tan Wee Seng, Mr. Liu Zhengdong and Mr. Zhuo Fumin.

Notes:

1. Details of the above resolutions are set out in the supplemental circular of the Company dated 31 May 2016 (the "Supplemental Circular").

2. A supplemental form of proxy in respect of the above resolutions has been enclosed with the Supplemental Circular.

3. Please refer to the Company's circular dated 29 April 2016 and the Notice for details of the other resolutions to be proposed at the AGM, eligibility for attending the AGM, appointment of proxy, registration procedures, closure of register of members and other relevant matters.